Repositrak CEO Fields sells shares worth $113,730

Published 30/10/2025, 21:58
Repositrak CEO Fields sells shares worth $113,730

ReposiTrak, Inc. (NASDAQ:TRAK) Chief Executive Officer Randall K. Fields, through RK Fields Charitable 2022, LLC, sold a total of 7,500 shares of common stock between October 28 and October 30, 2025. The sales amounted to approximately $113,730, with prices ranging from $14.9978 to $15.2786. The stock currently trades at $15.06, near its InvestingPro Fair Value, after experiencing a significant 30.22% decline over the past six months.

The sales were executed in three separate transactions. On October 28, 3,800 shares were sold at a price of $15.2786. On October 29, 1,000 shares were sold at $15.1774. The final transaction occurred on October 30, with 2,700 shares sold at $14.9978.

These sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC. The trading plan was established to enable Fields to meet some of his charitable commitments. Following these transactions, RK Fields Charitable 2022, LLC directly holds 27,500 shares.

Fields also directly owns 3,683,955 shares of common stock. In addition, Riverview Financial Corp. holds 615,260 shares of common stock and 289,673 shares of Series B Preferred Stock. Fields’ spouse holds 30,667 shares of common stock and 6,721 shares of Series B Preferred Stock, while Fields Management, Inc. holds 333,643 shares of common stock.ReposiTrak maintains impressive financial health with a "GREAT" overall score according to InvestingPro analysis. The company boasts strong fundamentals with 83.72% gross profit margins and holds more cash than debt on its balance sheet. Investors should note that TRAK is trading at a high P/E ratio of 42.83, with earnings results expected on November 17. InvestingPro offers 12 additional tips and comprehensive research reports on this and 1,400+ other US stocks to help investors make more informed decisions.

In other recent news, ReposiTrak reported its fourth-quarter earnings for 2025, with earnings per share aligning with forecasts at $0.09. However, the company fell short of revenue expectations, reporting $5.8 million against an anticipated $6.25 million, marking a 7.2% shortfall. In addition to financial results, ReposiTrak announced that 23 food suppliers have joined its Traceability Network. This initiative allows for the exchange of FDA-required data with retail customers. Among the new participants are a Quebec-based maple syrup producers’ cooperative, a California beverage company, and a Pennsylvania specialty condiment manufacturer. These developments highlight ReposiTrak’s ongoing efforts to expand its network and services.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.